Fig. 5

Main barriers of the current drug–drug interaction clinical decision support system. Panel A: a too broad screening interval leading to false positive alerts when switching correctly between anticoagulants. Panel B: lack of incorporation of patient-specific characteristics leading to false positive alerts when two QTc-prolonging drugs are prescribed for a patient whose QTc-interval is not prolonged